中文English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 36 Issue 9
Sep.  2020
Turn off MathJax
Article Contents

Value of fibrosis-4,aspartate aminotransferase-to-platelet ratio index,and globulin-platelet index in the diagnosis of significant liver fibrosis in autoimmune hepatitis

DOI: 10.3969/j.issn.1001-5256.2020.09.009
  • Received Date: 2020-03-30
  • Published Date: 2020-09-20
  • Objective To investigate the value of fibrosis-4( FIB-4),aspartate aminotransferase-to-platelet ratio index( APRI),and globulin-platelet index( GPI) in the diagnosis of significant liver fibrosis in autoimmune hepatitis( AIH). Methods A total of 47 AIH patients who were hospitalized and underwent liver biopsy in The First Affiliated Hospital of Anhui Medical University from November 2011 to May 2019 were enrolled as AIH group,and 47 healthy individuals,matched for age and sex,were enrolled as control group. According to the pathological results,AIH patients were divided into mild liver fibrosis( S1) group with 16 patients and significant liver fibrosis( S2-S4) group with 31 patients. The two groups were compared in terms of age,routine blood test results,and biochemical indices,and FIB-4,APRI,and GPI were calculated and compared between the two groups. The independent samples t-test was used for comparison of normally distributed continuous data between the two groups,and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between the two groups. A univariate binary logistic regression analysis was used to investigate the risk factors for significant liver fibrosis,and the area under the receiver operating characteristic curve( AUC) was used to compare the diagnostic value of each model. Results Compared with the control group,the AIH group had significant increases in globulin,alanine aminotransferase,aspartate aminotransferase,alkaline phosphatase,gamma-glutamyl transpeptidase( GGT),FIB-4,APRI,and GPI and significant reductions in platelet count( PLT) and albumin( all P < 0. 05). Compared with the mild liver fibrosis group,the significant liver fibrosis group had significant increases in age( t =-2. 681,P = 0. 010),FIB-4( Z =-3. 053,P = 0. 002),and GPI( Z =-3. 457,P = 0. 001) and significant reductions in PLT( t = 3. 185,P = 0. 003) and GGT( Z =-2. 290,P = 0. 022). The univariate analysis showed that age( odds ratio[OR]= 1. 074,95% confidence interval [CI]: 1. 013-1. 139,P = 0. 017),PLT( OR = 0. 987,95% CI: 0. 978-0. 997,P = 0. 010),FIB-4( OR = 1. 339,95% CI: 1. 046-1. 713,P = 0. 021),and GPI( OR = 4. 449,95% CI: 1. 319-15. 008,P = 0. 016) were influencing factors for significant liver fibrosis in AIH patients. FIB-4 and PLT had an AUC of 0. 774 and 0. 746,respectively,in the diagnosis of significant liver fibrosis in AIH patients,and GPI had an AUC of 0. 810,a sensitivity of 83. 9%,a specificity of 81. 2%,a positive predictive value of 89. 7%,and a negative predictive value of 72. 2% in the diagnosis of significant liver fibrosis and was superior to FIB-4 and PLT. APRI had no value in the diagnosis of significant liver fibrosis in AIH patients( P = 0. 271). Conclusion GPI has a certain value in predicting significant liver fibrosis in AIH patients and thus helps to reduce the need for liver biopsy in some patients.

     

  • loading
  • [1] CZAJA AJ. Review article:The prevention and reversal of hepatic fibrosis in autoimmune hepatitis[J]. Aliment Pharmacol Ther,2014,39(4):385-406.
    [2] LIU XD,WU JL,LIANG J,et al. Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patients[J]. World J Gastroenterol,2012,18(22):2784-2792.
    [3] HENNES EM,ZENIYA M,CZAJA AJ,et al. Simplified criteria for the diagnosis of autoimmune hepatitis[J]. Hepatology,2008,48(1):169-176.
    [4] ALVAREZ F,BERG PA,BIANCHI FB,et al. International autoimmune hepatitis group report:Review of criteria for diagnosis of autoimmune hepatitis[J]. J Hepatol,1999,31(5):929-938.
    [5] Chinese Society of Infectious Diseases and Parasitology,Chinese Society of Hepatology, Chinese Medical Association.Prevention and treatment of viral hepatitis[J]. Chin J Infect Dis,2001,19(1):56-62.(in Chinese)中华医学会传染病与寄生虫病学分会、肝病学分会.病毒性肝炎防治方案[J].中华传染病杂志,2001,19(1):56-62.
    [6] THANDASSERY RB,AL KAABI S,SOOFI ME,et al. Mean platelet volume,red cell distribution width to platelet count ratio,globulin platelet index,and 16 other indirect noninvasive fibrosis scores:How much do routine blood tests tell about liver fibrosis in chronic hepatitis C?[J]. J Clin Gastroenterol,2016,50(6):518-523.
    [7] LI Q,LU C,LI W,et al. Globulin-platelet model predicts significant fibrosis and cirrhosis in CHB patients with high HBV DNA and mildly elevated alanine transaminase levels[J]. Clin Exp Med,2018,18(1):71-78.
    [8] WANG J,YAN X,YANG Y,et al. A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B[J]. Oncotarget,2017,8(35):59257-59267.
    [9] WANG H,XU H,QU L,et al. Red blood cell distribution width and globulin,noninvasive indicators of fibrosis and inflammation in chronic hepatitis patients[J]. Eur J Gastroenterol Hepatol,2016,28(9):997-1002.
    [10] WANG H,WANG J,HUANG R,et al. Red blood cell distribution width for predicting significant liver inflammation in patients with autoimmune hepatitis[J]. Eur J Gastroenterol Hepatol,2019,31(12):1527-1532.
    [11] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Consensus on the diagnosis and therapy of hepatic fibrosis(2019)[J]. J Clin Hepatol,2019,35(10):2163-2172.(in Chinese)中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.肝纤维化诊断及治疗共识(2019年)[J].临床肝胆病杂志,2019,35(10):2163-2172.
    [12] ZENG T,YU J,TAN L,et al. Noninvasive indices for monitoring disease course in Chinese patients with autoimmune hepatitis[J]. Clin Chim Acta,2018,486:135-141.
    [13] ZHOU GQ,ZHONG QH,WANG RB,et al. Value of fibrosis-4index in diagnosis of liver fibrosis in autoimmune hepatitis[J]. J Clin Hepatol,2017,33(8):1487-1491.(in Chinese)周桂琴,钟启华,王融冰,等.FIB-4指数对自身免疫性肝炎肝纤维化的诊断价值[J].临床肝胆病杂志,2017,33(8):1487-1491.
    [14] LIU L,CAO J,ZHONG Z,et al. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients[J]. J Clin Lab Anal,2019,33(7):e22922.
    [15] LI YQ,DONG HJ,LIU XW,et al. Latest clinical advances in autoimmune hepatitis in special populations and special types of autoimmune hepatitis[J]. J Clin Hepatol,2018,34(6):1338-1342.(in Chinese)李艳清,董洪静,刘晓雯,等.特殊人群及特殊类型自身免疫性肝炎的临床新进展[J].临床肝胆病杂志,2018,34(6):1338-1342.
    [16] CHEN J,ESLICK GD,WELTMAN M. Systematic review with meta-analysis:Clinical manifestations and management of autoimmune hepatitis in the elderly[J]. Aliment Pharmacol Ther,2014,39(2):117-124.
    [17] ZACHOU K,GATSELIS N,PAPADAMOU G,et al. Mycophenolate for the treatment of autoimmune hepatitis:Prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment-nave patients[J]. J Hepatol,2011,55(3):636-646.
    [18] LI Q,LI W,HUANG Y,et al. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBe Ag-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China[J]. J Viral Hepat,2016,23(11):912-919.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (1314) PDF downloads(131) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return